Johnson & Johnson earnings: Expect a slow first quarter due to drug segment challenges By: MarketWatch April 17, 2017 at 12:48 PM EDT Last year was a strong fiscal year for the company. This one should be more difficult. Read More >> Related Stocks: Johnson & Johnson Merck & Co Mylan